Komori
Tms (4891) · RiskFirst stated

Continuation of Joint Research with Universities and Research Institutions

First written in FY2023. . Latest entry: FY2023.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Risk of Research Cost Burden and Difficulty Continuing Joint Research with UniversitiesA theme 5 companies write about · 5 as a headwind · 0 as a tailwind

0 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2023First statedAnnual report

    「If renewing these agreements becomes difficult for any reason, or if transactions become difficult because the agreements are terminated or otherwise ended, the Company’s business development could be materially affected, including through delays in R&D activities.」

    Difficulty renewing or termination of joint research agreements with Tokyo University of Agriculture and Technology and other institutions could delay R&D.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Tms yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Continuation of Joint Research with Universities and Research Institutions | TMS Co.,Ltd. (4891) | Komori